Northwest Biotherapeutics/ US66737P6007 /
2024-04-25 4:43:57 PM | Chg. +0.0099 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.4700USD | +2.15% | 582,017 Turnover: 276,336.5113 |
-Bid Size: - | -Ask Size: - | 0.4870 | 0.4601 |
GlobeNewswire
2023-08-25
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023
GlobeNewswire
2022-03-03
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
GlobeNewswire
2019-10-21
Global Human Vaccines Market 2015-2025 | by Disease, End-user & Leading Vaccine with Profiles on Key...
GlobeNewswire
2019-01-25
Immuno-oncology Development Trends and Opportunities, 2018 Research Report - Emerging Indications an...
GlobeNewswire
2018-09-21
Global Cancer Vaccine Market & Clinical Trial Insight 2025: Personalized Cancer Vaccine - The Next g...
GlobeNewswire
2018-03-27
Dendritic Cell Cancer Vaccine Market, 2024 - Dosage Price & Clinical Trials Outlook